Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Suppressing certain hormones might help prevent prostate cancer.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

A new compound was effective for imaging prostate cancer in rats.

Finasteride treats hair loss but may affect prostate cancer detection.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Higher cholesterol levels increase aggressive prostate cancer risk.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Gene variation affects prostate issues and hair loss.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Serum triglyceride levels are not linked to prostate cancer risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.